Odyssey Health, Inc. (ODYY) company profile
Close on Oct 19, 2026Market cap $746.34KP/E –Yield –
About Odyssey Health
Surgical & Medical Instruments & Apparatus, SIC 3841
Odyssey Health, Inc. is a medical technology company focused on acquiring and developing medical devices and technologies designed to address unmet clinical needs. The company operates across a single business segment and is developing two primary product candidates: CardioMap, a non-invasive heart monitoring and screening device intended to detect early signs of coronary heart disease, and Save-A-Life, an emergency choking rescue device designed to clear lodged obstructions from a victim's throat using vacuum suction. Odyssey Health does not currently market or sell any products commercially, as its technologies remain in development and require regulatory clearances, such as Food and Drug Administration approvals, prior to commercialization.
The company's planned end users include cardiologists, physicians, clinics, hospitals, sports teams, emergency facilities, and the general public, with prospective commercial distribution structured through industry partners and qualified distributors. Odyssey Health maintains its principal executive offices in Las Vegas, Nevada, and employs two individuals.
Summary of the business section of Odyssey Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Odyssey Health, Inc.
- Founded
- 2014
- Headquarters
- Las Vegas, NV
- Address
- 2300 West Sahara Avenue, Suite 800-#4012 89102
- Phone
- (702) 780-6559
- Website
- odysseyhealthinc.com
- Employees
- 2, Jul 31, 2026
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Nevada
- Fiscal year ends
- July 31
- Auditor
- Turner, Stone & Company, L.L.P., Dallas, Texas
Stock & identifiers
- Ticker
- ODYY
- Exchange
- OTC
- Shares outstanding
- 110M, Oct 27, 2026
- Public float
- $6.20M, Jan 31, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 1626644
- FIGI
- BBG007QQ7F07
- Share class FIGI
- BBG007QQ7F16
- EIN
- 47-1022125
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Odyssey Health's leadership is listed in its proxy statement, last filed Oct 30, 2023.
Employees
Headcount reported in annual reports
“At the date hereof, we have two employees and do not intend to hire additional employees in the foreseeable future.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?